brigatinib
SpainDrugs containing this active substance
-
It is used to treat a type of lung cancer in adults at advanced stages (non-small cell lung cancer) that presents an abnormal form of a gene called ALK.
Form: tablets, film-coated
Active substance Dosage brigatinib 180 mg Manufacturer: Takeda Pharma A/S
-
It is used to treat a type of lung cancer in adults in advanced stages called non-small cell lung cancer, provided that the cancer is related to an abnormal form of a gene called ALK.
Form: tablets, film-coated
Active substance Dosage brigatinib 30 mg Manufacturer: Takeda Pharma A/S
-
It is used to treat a type of lung cancer in adults at advanced stages (non-small cell lung cancer) that is related to an abnormal form of a gene called ALK.
Form: tablets, film-coated
Active substance Dosage brigatinib 90 mg brigatinib 180 mg Manufacturer: Takeda Pharma A/S
-
It is used to treat a type of lung cancer in adults in advanced stages (non-small cell lung cancer) that is related to an abnormal form of a gene called ALK.
Form: tablets, film-coated
Active substance Dosage brigatinib 90 mg Manufacturer: Takeda Pharma A/S